marketcaparena

SYRE

Spyre Therapeutics, Inc.

Company overview

Market capitalization
$7.56B
Employees
112
Latest publication
2026-09-29
About Spyre Therapeutics, Inc.

Spyre Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD) and rheumatic diseases. The company develops SPY001, a humanized monoclonal immunoglobulin G1 antibody that is in phase-2 clinical stage designed to bind selectively to the a4ß7 integrin being developed for the treatment of IBD (ulcerative colitis and Crohn's disease); and SPY002 and SPY072 " anti-TL1A mAbs designed to bind to tumor necrosis factor-like ligand 1A (TL1A). It is also developing SPY003, a clinical-stage program, which is in phase-2 clinical stage designed to bind to interleukin 23 (IL-23); SPY120, a combination of anti-a4ß7 and anti-TL1A mAbs; SPY130, a combination anti-a4ß7 and anti-IL-23 mAbs; and SPY230, a combination anti-TL1A and anti-IL-23 mAbs. The company was formerly known as Aeglea BioTherapeutics, Inc. and changed its name to Spyre Therapeutics, Inc. in November 2023. The company was incorporated in 2013 and is based in Waltham, Massachusetts.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USD
Total Revenue0USD0USD0USD0USD0USD0USD0USD0USD
Research Development60,411,000USD45,247,000USD40,145,000USD41,623,000USD50,482,000USD44,744,000USD32,636,000USD34,928,000USD
Selling General Administrative15,230,000USD11,641,000USD11,790,000USD11,944,000USD10,771,000USD10,648,000USD11,511,000USD12,846,000USD
Total Operating Expenses75,641,000USD11,641,000USD41,935,000USD53,567,000USD61,253,000USD55,392,000USD44,147,000USD47,774,000USD
Operating Income-75,641,000USD-56,888,000USD-41,935,000USD-53,567,000USD-61,253,000USD-55,392,000USD-44,147,000USD-47,774,000USD
Interest Income6,995,000USD5,379,000USD5,874,000USD6,493,000USD5,776,000USD5,184,000USD5,920,000USD4,432,000USD
Net Interest Income6,995,000USD5,379,000USD5,874,000USD6,493,000USD5,776,000USD5,184,000USD5,920,000USD4,432,000USD
Income Before Tax-69,005,000USD-11,183,000USD-36,717,000USD-44,788,000USD-56,295,000USD-69,010,000USD-38,837,000USD-43,825,000USD
Tax Provision0USD0USD0USD-15,000USD1,000USD18,000USD0USD32,000USD
Net Income-69,005,000USD-11,183,000USD-36,717,000USD-44,773,000USD-56,296,000USD-69,028,000USD-38,837,000USD-43,857,000USD
Net Income From Continuing Ops-69,005,000USD-11,183,000USD-36,717,000USD-44,773,000USD-56,296,000USD-69,028,000USD-38,837,000USD-43,857,000USD
Ebitda-69,005,000USD-11,183,000USD-51,935,000USD-44,788,000USD-56,295,000USD-69,010,000USD-38,837,000USD-43,825,000USD
Total Other Income Expense Net6,636,000USD45,705,000USD5,218,000USD8,779,000USD4,958,000USD-13,618,000USD5,310,000USD3,949,000USD
Cost Of Revenue—45,247,000USD——————
Gross Profit—-45,247,000USD——————
Unclassified Operating Expenses—-45,247,000USD-10,000,000USD—————
Income Tax Expense———-15,000USD1,000USD18,000USD—32,000USD
Interest Expense————21,312,000USD———
Ebit————-56,295,000USD——-47,817,276USD
Depreciation And Amortization————-4,958,000USD——43,276USD
Reconciled Depreciation————0USD0USD0USD0USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Revenue0USD886,000USD886,000USD2,329,000USD18,739,000USD0USD0USD3,888,000USD
Cost Of Revenue171,653,000USD964,000USD964,000USD1,964,000USD2,001,000USD1,624,000USD901,000USD—
Gross Profit-171,653,000USD886,000USD-78,000USD2,329,000USD18,739,000USD-1,624,000USD-901,000USD3,888,000USD
Research Development171,653,000USD162,790,000USD89,504,000USD58,579,000USD57,069,000USD59,638,000USD64,600,000USD36,719,000USD
Selling General Administrative47,909,000USD45,776,000USD39,946,000USD28,531,000USD27,319,000USD21,843,000USD17,801,000USD—
Unclassified Operating Expenses-181,653,000USD—113,739,000USD——-1,624,000USD-2,968,000USD12,632,000USD
Total Operating Expenses37,909,000USD208,566,000USD243,189,000USD87,110,000USD84,388,000USD79,857,000USD79,433,000USD49,351,000USD
Operating Income-209,562,000USD-208,566,000USD-242,303,000USD-84,781,000USD-65,649,000USD-81,481,000USD-80,334,000USD-45,463,000USD
Interest Income24,885,000USD21,312,000USD6,147,000USD837,000USD111,000USD593,000USD1,478,000USD—
Net Interest Income24,885,000USD21,312,000USD6,147,000USD837,000USD111,000USD593,000USD1,478,000USD—
Income Before Tax-155,218,000USD-207,967,000USD-338,816,000USD-83,951,000USD-65,660,000USD-80,893,000USD-78,254,000USD-44,348,000USD
Income Tax Expense-15,000USD51,000USD-26,000USD-136,000USD141,000USD-593,000USD——
Tax Provision-15,000USD51,000USD-26,000USD-136,000USD141,000USD0USD——
Net Income-155,203,000USD-208,018,000USD-338,790,000USD-83,815,000USD-65,801,000USD-80,893,000USD-78,254,000USD-44,348,000USD
Net Income From Continuing Ops-155,203,000USD-208,018,000USD-338,790,000USD-83,815,000USD-65,801,000USD-80,893,000USD-83,214,000USD—
Ebit-219,562,000USD-128,564,000USD-243,047,000USD-83,951,000USD-65,660,000USD-80,893,000USD-78,254,000USD-45,463,000USD
Ebitda-209,562,000USD-207,967,000USD-242,303,000USD-81,987,000USD-64,084,000USD-79,269,000USD-77,353,000USD-45,170,000USD
Depreciation And Amortization10,000,000USD964,000USD744,000USD1,964,000USD1,576,000USD1,624,000USD901,000USD293,000USD
Reconciled Depreciation0USD0USD744,000USD1,567,000USD1,576,000USD996,000USD587,000USD—
Total Other Income Expense Net54,344,000USD599,000USD-96,513,000USD830,000USD-11,000USD588,000USD2,080,000USD1,115,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Assets1,173,003,000USD763,953,000USD777,781,000USD504,604,000USD538,832,000USD569,778,000USD608,484,000USD421,089,000USD
Cash And Equivalents162,007,000USD———————
Cash And Short Term Investments1,100,000,000USD741,467,000USD756,533,000USD486,198,000USD526,580,000USD564,820,000USD603,088,000USD414,227,000USD
Total Current Assets1,173,003,000USD763,953,000USD777,781,000USD504,604,000USD538,832,000USD569,768,000USD608,474,000USD421,079,000USD
Other Current Assets27,657,000USD17,886,000USD21,248,000USD18,406,000USD12,252,000USD4,948,000USD5,386,000USD6,852,000USD
Total Liabilities71,862,000USD———————
Total Current Liabilities63,302,000USD85,162,000USD58,685,000USD46,274,000USD83,059,000USD70,678,000USD54,060,000USD57,539,000USD
Other Non Current Liabilities1,290,000USD———————
Total Stockholder Equity1,101,141,000USD670,811,000USD715,236,000USD455,100,000USD455,773,000USD482,610,000USD517,804,000USD327,390,000USD
Total Equity Including Noncontrolling Interest1,101,141,000USD———————
Common Stock16,000USD15,000USD15,000USD13,000USD13,000USD13,000USD13,000USD12,000USD
Retained Earnings-1,232,840,000USD-1,196,640,000USD-1,127,635,000USD-1,065,105,000USD-1,053,922,000USD-1,017,205,000USD-972,432,000USD-916,136,000USD
Accumulated Other Comprehensive Income-2,396,000USD-767,000USD869,000USD791,000USD454,000USD682,000USD180,000USD1,457,000USD
Total Liab—93,142,000USD62,545,000USD49,504,000USD83,059,000USD87,168,000USD90,680,000USD93,699,000USD
Other Current Liab—79,470,000USD49,781,000USD38,817,000USD79,347,000USD66,989,000USD53,394,000USD52,374,000USD
Capital Stock—155,835,000USD155,835,000USD155,833,000USD155,833,000USD155,833,000USD155,833,000USD155,832,000USD
Cash—97,185,000USD85,721,000USD64,897,000USD81,659,000USD48,493,000USD89,423,000USD71,580,000USD
Net Debt—-97,185,000USD-85,721,000USD-64,897,000USD-81,659,000USD-48,493,000USD-89,423,000USD-71,580,000USD
Short Term Investments—644,282,000USD670,812,000USD421,301,000USD444,921,000USD516,327,000USD513,665,000USD342,647,000USD
Net Receivables—4,600,000USD—3,600,000USD3,500,000USD———
Accounts Payable—5,692,000USD8,904,000USD7,457,000USD3,712,000USD3,689,000USD666,000USD5,165,000USD
Common Stock Shares Outstanding—346,045,000shares346,045,000shares60,414,223shares60,696,550shares60,265,932shares47,027,638shares50,889,433shares
Non Current Assets Total—0USD0USD0USD0USD10,000USD10,000USD10,000USD
Non Current Liabilities Total—7,979,999USD3,860,000USD3,230,000USD0USD16,490,000USD36,620,000USD36,160,000USD
Non Current Liabilities Other—7,980,000USD3,860,000USD3,230,000USD—16,490,000USD36,620,000USD36,160,000USD
Net Working Capital—678,791,000USD719,096,000USD458,330,000USD455,773,000USD499,090,000USD554,414,000USD363,540,000USD
Unclassified Equity—1,712,368,000USD1,686,152,000USD1,363,568,000USD1,353,395,000USD1,343,287,000USD1,334,210,000USD1,086,225,000USD
Non Currrent Assets Other—————10,000USD10,000USD10,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Assets777,781,000USD608,484,000USD341,859,000USD71,144,000USD109,926,000USD161,618,000USD83,183,000USD77,739,000USD
Other Current Assets21,248,000USD5,386,000USD2,251,000USD6,172,000USD4,948,000USD3,516,000USD2,556,000USD2,158,000USD
Total Liab62,545,000USD90,680,000USD157,843,000USD20,839,000USD25,985,000USD21,786,000USD23,102,000USD10,311,000USD
Total Stockholder Equity715,236,000USD517,804,000USD184,016,000USD50,305,000USD83,941,000USD139,832,000USD60,081,000USD67,428,000USD
Other Current Liab49,781,000USD53,394,000USD31,082,000USD12,837,000USD14,030,000USD464,000USD14,826,000USD9,576,000USD
Common Stock15,000USD13,000USD10,000USD6,000USD5,000USD5,000USD3,000USD2,000USD
Capital Stock155,835,000USD155,833,000USD184,937,000USD6,000USD5,000USD5,000USD3,000USD—
Retained Earnings-1,127,635,000USD-972,432,000USD-764,414,000USD-425,624,000USD-341,809,000USD-276,008,000USD-195,115,000USD-116,861,000USD
Cash85,721,000USD89,423,000USD188,893,000USD34,863,000USD15,142,000USD90,095,000USD19,253,000USD22,461,000USD
Cash And Short Term Investments756,533,000USD603,088,000USD339,277,000USD55,711,000USD93,128,000USD146,273,000USD71,949,000USD74,513,000USD
Total Current Assets777,781,000USD608,474,000USD341,528,000USD62,258,000USD98,891,000USD149,789,000USD74,505,000USD76,671,000USD
Total Current Liabilities58,685,000USD54,060,000USD31,978,000USD14,656,000USD20,144,000USD16,443,000USD18,359,000USD10,239,000USD
Net Debt-85,721,000USD-89,423,000USD-104,338,000USD-30,234,000USD-10,082,000USD-84,647,000USD-14,131,000USD-22,461,000USD
Short Term Investments670,812,000USD513,665,000USD150,384,000USD20,848,000USD77,986,000USD56,178,000USD52,696,000USD52,052,000USD
Accounts Payable8,904,000USD666,000USD896,000USD677,000USD3,319,000USD2,254,000USD3,154,000USD663,000USD
Accumulated Other Comprehensive Income869,000USD180,000USD302,000USD-48,000USD-20,000USD11,000USD51,000USD-27,000USD
Common Stock Shares Outstanding346,045,000shares47,027,638shares6,897,065shares3,371,231shares2,629,784shares2,134,869shares1,277,985shares832,902shares
Non Current Assets Total0USD10,000USD331,000USD8,886,000USD11,035,000USD11,829,000USD8,678,000USD1,068,000USD
Non Current Liabilities Total3,860,000USD36,620,000USD125,865,000USD6,183,000USD5,841,000USD5,343,000USD4,742,999USD72,000USD
Non Current Liabilities Other3,860,000USD36,620,000USD41,310,000USD—16,000USD214,000USD31,000USD—
Net Working Capital719,096,000USD554,414,000USD309,550,000USD47,602,000USD78,747,000USD133,346,000USD56,146,000USD—
Unclassified Equity1,686,152,000USD1,334,210,000USD763,181,000USD475,965,000USD425,760,000USD415,819,000USD255,139,000USD184,314,000USD
Short Long Term Debt Total—84,555,000USD84,555,000USD4,629,000USD5,060,000USD5,448,000USD5,122,000USD—
Non Currrent Assets Other—10,000USD9,000USD683,000USD842,000USD115,000USD11,000USD50,000USD
Property Plant Equipment Net——0USD6,650,000USD8,355,000USD9,872,000USD7,167,000USD1,018,000USD
Property Plant Equipment Gross——0USD10,794,000USD11,157,000USD11,855,000USD7,111,000USD—
Unclassified Non Current Liabilities——84,555,000USD6,183,000USD5,825,000USD5,129,000USD4,711,999USD—
Current Deferred Revenue———517,000USD2,359,000USD13,406,000USD——
Short Term Debt———625,000USD436,000USD319,000USD379,000USD—
Net Receivables———375,000USD815,000USD——300,000USD
Unclassified Non Current Assets———1,553,000USD1,838,000USD1,842,000USD1,500,000USD—
Other Assets———————1USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow YTD

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USD
Stock Based Compensation26,318,000USD
Change To Liabilities225,000USD
Change In Working Capital-5,841,000USD
Operating Cash Flow-127,249,000USD
Net Investments-311,323,000USD
Unclassified Investing Cash Flow70,000,000USD
Investing Cash Flow-241,323,000USD
Common Stock Issuance23,255,000USD
Unclassified Financing Cash Flow421,603,000USD
Financing Cash Flow444,858,000USD
Change In Cash76,286,000USD
End Cash Flow162,007,000USD
SourceDisclosureDeterministicFinal

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Net Income-69,005,000USD-51,831,000USD-11,183,000USD-36,717,000USD-44,773,000USD-56,296,000USD-69,028,000USD-38,837,000USD
Stock Based Compensation12,806,000USD9,811,000USD9,566,000USD9,378,000USD8,859,000USD9,216,000USD13,100,000USD8,682,000USD
Other Non Cash Items11,218,000USD7,797,000USD-41,440,000USD-10,183,000USD-4,512,000USD-917,000USD16,156,000USD-2,937,000USD
Change In Working Capital244,000USD-2,265,000USD5,940,000USD-9,041,000USD-568,000USD10,798,000USD10,351,000USD-29,156,000USD
Total Cash From Operating Activities-57,543,000USD-44,578,000USD-37,117,000USD-46,563,000USD-40,994,000USD-37,199,000USD-29,421,000USD-62,248,000USD
Capital Expenditures0USD0USD0USD0USD0USD0USD0USD0USD
Free Cash Flow-57,543,000USD-44,578,000USD-37,117,000USD-46,563,000USD-40,994,000USD-37,199,000USD-29,421,000USD-62,248,000USD
Investments26,581,000USD-247,410,000USD24,998,000USD78,998,000USD-61,000USD-170,544,000USD42,740,000USD-120,518,000USD
Total Cashflows From Investing Activities56,581,000USD-247,410,000USD24,998,000USD78,998,000USD-61,000USD-170,544,000USD42,740,000USD-120,518,000USD
Total Cash From Financing Activities12,426,000USD312,812,000USD-4,643,000USD731,000USD125,000USD225,601,000USD12,780,000USD360,000USD
Issuance Of Capital Stock9,750,000USD311,132,000USD0USD0USD0USD224,622,000USD11,540,000USD-135,000USD
Change In Cash11,464,000USD20,824,000USD-16,762,000USD33,166,000USD-40,930,000USD17,843,000USD26,115,000USD-182,408,000USD
Begin Period Cash Flow85,721,000USD64,897,000USD81,659,000USD48,493,000USD89,423,000USD71,580,000USD45,465,000USD227,552,000USD
End Period Cash Flow97,185,000USD85,721,000USD64,897,000USD81,659,000USD48,493,000USD89,423,000USD71,580,000USD45,144,000USD
Other Cashflows From Investing Activities30,000,000USD——7,000,000USD————
Unclassified Operating Cash Flow-12,806,000USD————11,404,000USD——
Unclassified Financing Cash Flow2,676,000USD312,764,000USD————-168,850,000USD—
Depreciation—-8,090,000USD———-11,404,000USD0USD0USD
Sale Purchase Of Stock—117,000USD—0USD-117,000USD——0USD
Other Cashflows From Financing Activities—-69,000USD-5,134,000USD-117,000USD242,000USD979,000USD170,090,000USD495,000USD
Unclassified Investing Cash Flow———-7,000,000USD————
Net Borrowings—————0USD0USD—
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Net Income-155,203,000USD-208,018,000USD-338,790,000USD-83,815,000USD-65,801,000USD-80,893,000USD-78,254,000USD-44,348,000USD
Depreciation-8,090,000USD744,000USD744,000USD1,567,000USD1,576,000USD996,000USD901,000USD293,000USD
Stock Based Compensation37,614,000USD44,833,000USD25,675,000USD7,111,000USD8,038,000USD6,256,000USD5,498,000USD—
Other Non Cash Items-37,639,000USD10,309,000USD217,667,000USD823,000USD638,000USD619,000USD3,776,000USD1,930,000USD
Change In Working Capital-5,934,000USD-4,534,000USD-5,206,000USD-5,503,000USD1,833,000USD-2,540,000USD7,104,000USD7,201,000USD
Total Cash From Operating Activities-169,252,000USD-157,410,000USD-99,910,000USD-80,144,000USD-53,716,000USD-75,775,000USD-65,692,000USD-32,193,000USD
Capital Expenditures0USD0USD0USD-38,000USD-573,000USD-4,280,000USD-1,492,000USD-422,000USD
Free Cash Flow-169,252,000USD-157,410,000USD-99,910,000USD-80,182,000USD-54,289,000USD-80,055,000USD-67,184,000USD-32,615,000USD
Investments-150,475,000USD-353,285,000USD-108,393,000USD57,008,000USD-22,619,000USD-7,604,000USD-15,670,000USD—
Total Cashflows From Investing Activities-143,475,000USD-353,285,000USD—57,008,000USD-22,619,000USD-7,604,000USD-1,739,000USD-15,231,000USD
Total Cash From Financing Activities309,025,000USD410,906,000USD361,077,000USD42,678,000USD1,393,000USD154,512,000USD65,723,000USD57,068,000USD
Issuance Of Capital Stock311,132,000USD405,232,000USD366,474,000USD42,874,000USD0USD153,716,000USD129,250,000USD—
Change In Cash-3,702,000USD-99,792,000USD152,799,000USD19,436,000USD-74,957,000USD71,184,000USD-3,208,000USD9,644,000USD
Begin Period Cash Flow89,423,000USD189,215,000USD36,416,000USD16,980,000USD91,937,000USD20,753,000USD22,461,000USD12,817,000USD
End Period Cash Flow85,721,000USD89,423,000USD189,215,000USD36,416,000USD16,980,000USD91,937,000USD19,253,000USD22,461,000USD
Other Cashflows From Investing Activities7,000,000USD15,475,000USD——————
Other Cashflows From Financing Activities-5,413,000USD174,524,000USD191,983,000USD222,000USD1,903,000USD816,000USD1,450,000USD3,020,000USD
Unclassified Financing Cash Flow3,306,000USD-168,850,000USD-197,364,000USD———-64,977,000USD54,048,000USD
Change To Account Receivables—375,000USD375,000USD440,000USD-815,000USD——3,078,000USD
Net Borrowings—0USD-16,000USD-418,000USD-510,000USD———
Unclassified Investing Cash Flow—-15,475,000USD———4,280,000USD15,423,000USD-14,809,000USD
Change To Inventory——-375,000USD-440,000USD————
Unclassified Operating Cash Flow——————-4,717,000USD2,731,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
FY 2023Yearly · 2023-12-31ProductDevelopment Fee And Royalty886,000USD0001636282-24-000005
FY 2023Yearly · 2023-12-31ProductLicense0USD0001636282-24-000005
FY 2022Yearly · 2022-12-31ProductDevelopment Fee And Royalty2,329,000USD0001636282-24-000005
FY 2022Yearly · 2022-12-31ProductLicense0USD0001636282-24-000005
Q3 2022Quarterly · 2022-09-30ProductDevelopment Fee174,000USD0000950170-22-021529
Q3 2022Quarterly · 2022-09-30ProductLicense0USD0000950170-22-021529
FY 2021Yearly · 2021-12-31ProductDevelopment Fee And Royalty6,739,000USD0001636282-24-000005
FY 2021Yearly · 2021-12-31ProductLicense12,000,000USD0001636282-24-000005
Q3 2021Quarterly · 2021-09-30ProductDevelopment Fee1,399,000USD0000950170-22-021529
Q3 2021Quarterly · 2021-09-30ProductLicense0USD0000950170-22-021529
Q2 2021Quarterly · 2021-06-30ProductDevelopment Fee1,696,000USD0001564590-22-027895
Q2 2021Quarterly · 2021-06-30ProductLicense12,000,000USD0001564590-22-027895

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.